Orchid Pharma Ltd - 524372 - Dissolution Of Shareholder, M/S Orchid Health Care Private Ltd, Promoter Group Company
Dissolution of Shareholder, M/s Orchid Health Care Private Ltd, Promoter Group Company31-12-2019
31-12-2019
Orchid Pharma Ltd - 524372 - Registrar Of Companies, Chennai, Order For Extension Of Holding 26Th Annual General Meeting Of The Company For The FY 2018-19
In terms of the provisions of Section 96 of the Companies Act, 2013 and the rules made thereunder, the Company has obtained approval from the Registrar of Companies, Chennai, for extension of time for holding 26th Annual General Meeting (AGM) of the Company.13-12-2019
Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 23(9) Of The SEBI (LODR) Regulations, 2015
Pursuant to Regulation 23(9) of the SEBI (LODR) Regulations, 2015, we hereby submit the disclosure of Related Party transactions for the half year ended September 30, 2019.10-12-2019
Orchid Pharma Ltd - 524372 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Pursuant to the ongoing Corporate Insolvency Resolution Process of the Company, we herewith enclose the interim order passed by Hon'ble Supreme Court, New Delhi on December 06, 2019.10-12-2019
Orchid Pharma Ltd - 524372 - Reg. 34 (1) Annual Report
Annual Report for the Financial Year 2018-19 cum NOTICE OF 26th Annual General Meeting 201906-12-2019
Orchid Pharma Ltd - 524372 - Annual General Meeting On Monday, December 30, 2019
In accordance with the requirements of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 26th Annual General Meeting of the Company has been proposed to be held on Monday, December 30, 2019 at 11.00 A.M. at Sri Thyaga Brahma Gana Sabha (Vani Mahal), No.103, G N Chetty Road, Parthasarathi Puram, T Nagar, Chennai - 600 017, Tamil Nadu, India.04-12-2019
Orchid Pharma Ltd - 524372 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Order passed by Hon'ble National Company Law Appellate Tribunal, New Delhi on November 13, 2019.14-11-2019
Orchid Pharma Ltd - 524372 - Outcome Of Board Meeting
Approval of Unaudited Financial Results for the Quarter ended September 30, 201914-11-2019
Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended September 30, 2019
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Resolution Professional shall hold a Meeting on Thursday, November 14, 2019, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2019.08-11-2019
Orchid Pharma Ltd - 524372 - Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations 2015
Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations 201525-10-2019